Use of the heart-rate lowering drug ivabradine can reduce the incidence of cardiovascular disease and death in patients with coronary artery disease and a high heart rate. These are the conclusions of the first of two Articles (the BEAUTIFUL study) published early Online and in an
upcoming edition of The Lancet; the moment write-up concludes higher resting heart rate in patients with coronary artery disease is a strong independent risk factor for death, heart attack and heart failure.Original post by Women’s Health / Gynecology News From Medical News Today